Elvitegravir Patent Expiration
Elvitegravir is Used for managing HIV infection. It was first introduced by Gilead Sciences Inc
Elvitegravir Patents
Given below is the list of patents protecting Elvitegravir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vitekta |
US7635704 (Pediatric) | Stable crystal of 4-oxoquinoline compound | Apr 26, 2027 | Gilead Sciences Inc |
| Vitekta |
US8981103 (Pediatric) | Stable crystal of 4-oxoquinoline compound | Apr 26, 2027 | Gilead Sciences Inc |
| Vitekta |
US7176220 (Pediatric) | 4-oxoquinoline compound and use thereof as pharmaceutical agent | Feb 27, 2027 | Gilead Sciences Inc |
| Vitekta | US7635704 | Stable crystal of 4-oxoquinoline compound | Oct 26, 2026 | Gilead Sciences Inc |
| Vitekta | US8981103 | Stable crystal of 4-oxoquinoline compound | Oct 26, 2026 | Gilead Sciences Inc |
| Vitekta | US7176220 | 4-oxoquinoline compound and use thereof as pharmaceutical agent | Aug 27, 2026 | Gilead Sciences Inc |
Elvitegravir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List